Non-Hodgkin Lymphoma

Fox, Christopher; Mead, Adam; Sellar, Rob
November 2011
Current Medical Literature: Leukemia & Lymphoma;2011, Vol. 19 Issue 4, p110
Academic Journal
The article discusses the findings of several studies on non-Hodgkin lymphoma. One study examined indolent mantle cell leukemia (MCL) with isolated blood and bone marrow involvement. Another examined the risk of central nervous system relapse in diffuse large B-cell lymphoma (DLBCL) patients. A third studied the impact of combined rituximab and doxorubicin, cyclophosphamide, vindesine, bleomycin and prednisolone (ACVBP) treatment for high-risk DLBCL patients.


Related Articles

  • Synchronous Primary Central Nervous System and Pulmonary Lymphoma in a 7-Year-Old Female with Unspecified T-Cell Immunodeficiency. Ghali, Michael¬†G.Z.; Samkari, Ayman; Hou, J.¬†Steve; Balasubramanian, Manjula; Besmer, Sherri; Keisling, Matthew; Narayan, Prithvi // Pediatric Neurosurgery;2018, Vol. 53 Issue 5, p311 

    Primary central nervous system lymphoma (PCNSL) is rare in children with immunocompromise as an important risk factor. A 7-year-old girl with unspecified T-cell immunodeficiency presented with left-sided weakness and was found to have a right-sided frontal lobe mass on imaging. The mass was...

  • Primary testicular lymphoma with cardiac involvement in an immunocompetent patient: case report and a concise review of literature. Dahiya, Saurabh; Ooi, Wei B.; Mallidi, Jaya; Sivalingam, Senthil; Steingart, Richard // Rare Tumors;2012, Vol. 4 Issue 3, p138 

    Primary testicular lymphoma (PTL) is a rare testicular tumor representing less than 9% of all testicular cancers. PTL usually tends to spread to or relapse at nodal structures or extra-nodal sites such as contralateral testes, central nervous system, skin, lung, pleura, waldeyer's ring and soft...

  • Session 9: pediatric lymphoma.  // Annals of Oncology;Apr2011 Supplement 4, Vol. 22 Issue suppl_4, piv112 

    No abstract available.

  • Hypothalamic dysfunction in a patient with primary lymphoma of the central nervous system. Antic, Darko; Smiljanic, Mihajlo; Bila, Jelena; Jankovic, Snezana; Todorovic, Milena; Andjelic, Bosko; Mihaljevic, Biljana // Neurological Sciences;Apr2012, Vol. 33 Issue 2, p387 

    A 60-year-old woman with no previous history of chronic disease or malignancy presented with intense back and left leg pain and sleep disturbances. The patient had been treated unsuccessfully for the past 6 months with analgetics. Magnetic resonance imaging showed a soft tissue tumor in the...

  • Dose-intensive R-ACVBP improved survival, increased adverse effects in LBCL. Lancet., Recher C. // Hem/Onc Today;12/25/2011, Vol. 12 Issue 24, p14 

    The article reveals the role of dose-intensive rituximab, doxorubicin, cyclophosphamide, vindesine, bleomycin and prednisone (R-ACVBP) in improving survival in younger patients with large B-cell carcinoma and in increasing grade-3/grade-4 hematologic toxic effects, according to research findings.

  • Local Treatment for Lymphoid Malignancies of the Eye. Giuliari, Gian Paolo; Hinkle, David M.; Foster, C. Stephen // Anti-Cancer Agents in Medicinal Chemistry;2009, Vol. 9 Issue 10, p1123 

    Lymphoid malignancies may affect the eye either as primary intraocular lymphomas (PIOL), or by secondary involvement of a nodal lymphoma. PIOL is a subtype of primary central nervous system (CNS) lymphoma and in up to 98% of the cases are non- Hodgkin's B cell lymphomas. PIOL may occur in...

  • Clinical features and treatment outcomes of isolated secondary central nervous system lymphomas in Miyazaki Prefecture. Kawano, Noriaki; Ochiai, Hidenobu; Yoshida, Shuro; Yamashita, Kiyoshi; Shide, Kotaro; Shimoda, Haruko; Hidaka, Tomonori; Kubuki, Yoko; Katayose, Keiko; Toyama, Takanori; Kawano, Hiroshi; Matsuoka, Hitoshi; Ishizaki, Junzo; Maeda, Koichi; Satou, Seiichi; Yano, Tatsuhiko; Yamaguchi, Kenichiro; Takenaka, Katsuto; Shimao, Yoshiya; Oshima, Koichi // International Journal of Clinical Oncology;Aug2012, Vol. 17 Issue 4, p336 

    Background: Secondary central nervous system lymphoma (SCNSL) without extra-central nervous system (CNS) involvement is characterized by isolated secondary CNS relapse in malignant lymphoma patients. SCNSL is a rare disease, and no standard treatment has yet been established. Patients and...

  • A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapy. Niitsu, Nozomi; Tamaru, Jun-ichi; Yoshino, Tadashi; Nakamura, Naoya; Nakamura, Shigeo; Ohshima, Kohichi; Nakamine, Hirokazu; Okamoto, Masataka // Annals of Hematology;Feb2011, Vol. 90 Issue 2, p185 

    In our previous study on nm23-H1 expression with diffuse large B-cell lymphoma (DLBCL), we found that patients with positive nm23-H1 had significantly poorer prognosis than patients with negative nm23-H1. We examined whether nm23-H1 is a prognostic factor of DLBCL in the rituximab era. The...

  • Primary Central Nervous System Lymphoma. Bhagavathi, Sharathkumar; Wilson, Jon D. // Archives of Pathology & Laboratory Medicine;Nov2008, Vol. 132 Issue 11, p1830 

    Primary central nervous system lymphoma (PCNSL) is an uncommon extranodal non-Hodgkin lymphoma. Its incidence has increased during the last 3 decades and has been reported in both immunocompromised and immunocompetent patients. Immunocompromised patients are affected at a younger age compared...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics